Fig. 2. Gross morphological and histological phenotype of
LAP-tTA/TRE-VEGFR2T newborn mice. (A) A dark-red appearance
distinguishes the LAP-tTA/TRE-VEGFR2T mutant livers from controls.
Dox suppresses this phenotype. (B,C) Body weight and liver/body weight ratios
of LAP-tTA/TRE-VEGFR2T newborns are comparable to LAP-tTA
controls. (D) Western blotting with an anti-albumin antibody. (E)
Insignificant reduction in hepatocyte proliferation in mutant livers by PCNA
staining. (F) No significant difference in apoptosis. The number of
proliferating cells (E) or apoptotic cells (F) is per 40 x microscopic
field. Error bars represent the s.d.